
Sharon Phares, PhD, MPH, discussed her new appointment as the chief scientific officer of the National Pharmaceutical Council (NPC) and her main priorities in honor of Women's Health Month.
During the Academy of Managed Care Pharmacy's Annual Meeting, Sharon Phares, PhD, MPH, discussed her new appointment as the chief scientific officer of the National Pharmaceutical Council (NPC) and her main priorities in honor of Women's Health Month.
Transcript
In your new role with the National Pharmaceutical Council, what will be your main areas of focus?
We have 3 strategic priorities. The first is looking at issues around the cost of pharmaceuticals and the supply chain. The second, looking at value, so HTA [health technology assessments] sort of issues. And then last, but not least, the most important is looking at issues that inform patient access and affordability.
Delgocitinib Is Redefining Chronic Hand Eczema Treatment: A Q&A With Raj Chovatiya, MD, PhD, MSCI
November 10th 2025Delgocitinib has emerged as a promising treatment for CHE, addressing unmet needs and enhancing understanding of this complex condition, notes Raj Chovatiya, MD, PhD, MSCI.
Read More
Delgocitinib Is Redefining Chronic Hand Eczema Treatment: A Q&A With Raj Chovatiya, MD, PhD, MSCI
November 10th 2025Delgocitinib has emerged as a promising treatment for CHE, addressing unmet needs and enhancing understanding of this complex condition, notes Raj Chovatiya, MD, PhD, MSCI.
Read More
2 Commerce Drive
Cranbury, NJ 08512